Comparison

Mc-MMAE European Partner

€523.00
Excl. VAT
Item no. HY-15741-1mg*5
Manufacturer MedChem Express
CASRN 863971-24-8
Amount 1 mg x 5
Category
Type Inhibitors
Specific against other
Purity 99.38
Formula C49H78N6O10
Citations [1]Sanderson RJ, et al. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):843-52.
Smiles O=C1N(CCCCCC(N(C)[C@H](C(N[C@@H](C(C)C)C(N([C@@H]([C@@H](C)CC)[C@@H](CC(N2[C@H]([C@H](OC)[C@H](C(N[C@@H]([C@H](C3=CC=CC=C3)O)C)=O)C)CCC2)=O)OC)C)=O)=O)C(C)C)=O)C(C=C1)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Maleimidocaproyl-monomethylauristatin E
Available
Product Description
Mc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a agent-linker conjugate for ADC.
StorageTemperature
4°C (Powder, stored under nitrogen)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
Molecular Weight
911.18
Clinical Information
No Development Reported
Solubility
DMSO : 180 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Isoform
Auristatin
Pathway
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type
ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg x 5
Available: In stock
Listprice: €523.00
Price: €523.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close